On the value of menorrhagia as a predictor for coagulation disorders

American Journal of Hematology

Volumn 53, Issue 4, 1996, Pages 234-238

  Edlund, Måns ^a   Blombäck, Margarete ^a   Von Schoultz, Bo ^a   Andersson, Ola ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

coagulation disorder; menorrhagia; platelet dysfunction; predictor; von Willebrand's disease

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; FEMALE; HUMAN; MENORRHAGIA; PRIORITY JOURNAL; THROMBOCYTE DYSFUNCTION; VON WILLEBRAND DISEASE;

ADULT; BLOOD CELL COUNT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BLOOD PROTEINS; FEMALE; HEMATOCRIT; HEMOGLOBINS; HEMOPHILIA A; HUMANS; MENORRHAGIA; MIDDLE AGED; PREVALENCE; VON WILLEBRAND DISEASE;

EID: 0029972247     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199612)53:4<234::AID-AJH4>3.0.CO;2-Z     Document Type: Article

References (26)

1. Wahlberg T, Blombäck M, Hall P, Axelsson G: Application of indicators, predictors and diagnostic indices in coagulation disorders. Methods Inf Med 19:194-200, 1980.
2. Parkin JD, Smith IL, O'Neill AI, Ibrahim KMA, Butcher LA: Mild bleeding disorders. A clinical and laboratory study. Med J Aust 156:614-617, 1992.
3. Chimbira TH, Andersen ABM, Turnbull AC: Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. Br J Obstet Gynaecol 87:603-609, 1980.
4. Fraser IS, Pearse C, Shearman RP, Elliott PM, McIlveen JRM: Efficacy of mefanamic acid in patients with a complaint of menorrhagia. Obstet Gynecol 58:543-551, 1981.
5. Fraser IS, McCarron G, Markham R: A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol 149:788-793, 1984.
6. Granleese J: Personality, sexual behavior and menstrual symptoms: Their relevance to clinically presenting menorrhagia. Person Individ Differ 11:379-390, 1990.
7. Edlund M, Magnusson C, von Schoultz B: Quality of life - A Swedish survey of 2200 women. In Smith SK (ed): "Dysfunctional Uterine Bleeding." London: The Royal Society of Medicine Press Ltd., 1994, pp 36-37.
8. Greer IA, Lowe GDO, Walker JJ, Forbes CD: Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 98:909-918, 1991.
9. Edlund M, Andersson K, Rybo G, Lindoff C, Åstedt B, von Schoultz B: Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161). Br J Obstet Gynaecol 102:913-917, 1995.
10. Hallberg L, Nilsson L: Determination of menstrual blood loss. Scand J Clin Lab Invest 16:244-248, 1964.
11. Mielke CH, Kaneshiro MM, Maher JA, Weiner JM, Rapaport SJ: The standardized normal bleeding time and its prolongation by aspirin. Blood 34:204-215, 1969.
12. Rosén S, Andersson M, Blombäck M, Hägglund U, Larrieu MJ, Wolf M, Boyer C, Rothschild C, Nilsson IM, Sjörin E, Winazzer H: Clinical applications of a chromogenic substrate method for determination of factor VIII activity. Thromb Haemost 54:818-823, 1985.
13. Bergström K, Egberg N: Determination of vitamin-K sensitive coagulation factors in plasma. Studies on three methods using synthetic chromogenic substrates. Thromb Res 12:531-547, 1978.
14. Teger-Nilsson AC, Friberger P, Gyzander E: Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin-specific tripeptide substrate. Scand J Clin Lab Invest 37:403-409, 1977.
15. Silveira AMV, Yamahoto T, Adamsson L, Hessel B, Blombäck B: Application of an enzyme-linked immuno-sorbent assay (ELISA) to von Willebrand factor (vWF) and its derivatives. Thromb Res 43:91-102, 1986.
16. Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN: Measurement of crosslinked fibrin degradation products - An immunoassay using monoclonal antibodies. Thromb Haemost 50:591, 1983.
17. Vermylen C, de Vreker RA, Verstraete M: A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT Test). Clin Chim Acta 8:418-424, 1963.
18. Wahlberg TB, Blombäck M, Ruggeri ZM: Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combination of factor VIII variables. Thromb Haemost 50:864-868, 1983.
19. Anvret M, Blombäck M, Lindstedt M, Söderlind E, Tapper-Persson M, Thelander A-C: Genetic and blood coagulalion characterization of "Swedish" families with von Willebrand's disease types I and III: New aspects of heredity. Hum Genet 89:147-154, 1992.
20. Blombäck M, Eneroth P, Andersson O, Anvret M: On laboratory problems in diagnosing mild von Willebrand's disease. Am J Hematol 40:117-120, 1992.
21. Zhang Z, Lindstedt M, Blombäck M, Anvret M: Effects of the mutant von Willebrand factor gene in von Willebrand disease. Hum Genet 96:388-394, 1995.
22. Rodeghiero F, Castaman G, Dini E: Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 69:454-459, 1987.
23. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shultz J, Abshire TC: Prevalence of von Willebrand disease in children: A multiethnic study. J Pediatr 123:893-898, 1993.
24. Blombäck M, Eneroth P, Landgren B-M, Lagerström M, Andersson O: On the intraindividual and gender variability of haemostatic components. Thromb Haemost 67:70-75, 1992.
25. Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS: Serial studies in von Willebrand's disease: Variability versus "variants." Blood 56:712-716, 1980.
26. Mandalaki T, Louizou C, Dmitriadou C, Symeonides PH: Variations in factor VIII during the menstrual cycle in normal women. N Engl J Med 302:1093, 1980.